Advertisement
Screener

Concert Pharmaceuticals, Inc. Financing Cash Flow

Concert Pharmaceuticals, Inc. Financing Cash Flow

Concert Pharmaceuticals, Inc. reported Financing Cash Flow of $90.85 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-07.

Discontinued › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2022-11-07

  • Concert Pharmaceuticals, Inc. net cash provided by (used in) financing activities for the quarter ending 2022-09-30 was $21.00M.
  • Concert Pharmaceuticals, Inc. net cash provided by (used in) financing activities for the quarter ending 2022-06-30 was $69.85M.
  • Concert Pharmaceuticals, Inc. net cash provided by (used in) financing activities for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
  • Concert Pharmaceuticals, Inc. net cash provided by (used in) financing activities for the quarter ending 2021-12-31 was $64.47M, a 189.98% increase year-over-year.
  • Concert Pharmaceuticals, Inc. net cash provided by (used in) financing activities for fiscal 2021 was $67.13M, a 27.70% decline from fiscal 2020.
  • Concert Pharmaceuticals, Inc. net cash provided by (used in) financing activities for fiscal 2020 was $92.85M, a 6299.17% increase from fiscal 2019.
  • Concert Pharmaceuticals, Inc. net cash provided by (used in) financing activities for fiscal 2019 was $1.45M.
  • Concert Pharmaceuticals, Inc. net cash provided by (used in) financing activities for fiscal 2018 was -$169.00K, a 103.08% decline from fiscal 2017.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 12 month
2022-09-30$21.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07
$90.85M
derived: sum of 2 quarters · filed 2022-11-07
$90.85M
10-Q · filed 2022-11-07
$155.32M
derived: sum of 4 quarters · filed 2022-11-07
2022-06-30$69.85M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
$69.85M
10-Q · filed 2022-08-04
$134.32M
derived: sum of 3 quarters · filed 2022-08-04
$134.32M
derived: sum of 4 quarters · filed 2022-11-07
2022-03-31$0.00
10-Q · filed 2022-05-05
$64.47M
derived: sum of 2 quarters · filed 2022-05-05
$64.47M
derived: sum of 3 quarters · filed 2022-11-07
$64.47M
derived: sum of 4 quarters · filed 2022-11-07
2021-12-31$64.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03
$64.47M
derived: sum of 2 quarters · filed 2022-11-07
$64.47M
derived: sum of 3 quarters · filed 2022-11-07
$67.13M
10-K · filed 2022-03-03
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07
$0.00
derived: sum of 2 quarters · filed 2022-11-07
$2.66M
10-Q · filed 2022-11-07
$24.89M
derived: sum of 4 quarters · filed 2022-11-07
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
$2.66M
10-Q · filed 2022-08-04
$24.89M
derived: sum of 3 quarters · filed 2022-08-04
$24.91M
derived: sum of 4 quarters · filed 2022-08-04
2021-03-31$2.66M
10-Q · filed 2022-05-05
$24.89M
derived: sum of 2 quarters · filed 2022-05-05
$24.91M
derived: sum of 3 quarters · filed 2022-05-05
$25.02M
derived: sum of 4 quarters · filed 2022-05-05
2020-12-31$22.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03
$22.24M
derived: sum of 2 quarters · filed 2022-03-03
$22.35M
derived: sum of 3 quarters · filed 2022-03-03
$92.85M
10-K · filed 2022-03-03
2020-09-30$13.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
$122.00K
derived: sum of 2 quarters · filed 2021-11-09
$70.62M
10-Q · filed 2021-11-09
$70.63M
derived: sum of 4 quarters · filed 2021-11-09
2020-06-30$109.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
$70.61M
10-Q · filed 2021-08-05
$70.62M
derived: sum of 3 quarters · filed 2021-08-05
$70.99M
derived: sum of 4 quarters · filed 2021-08-05
2020-03-31$70.50M
10-Q · filed 2021-05-04
$70.51M
derived: sum of 2 quarters · filed 2021-05-04
$70.88M
derived: sum of 3 quarters · filed 2021-05-04
$70.19M
derived: sum of 4 quarters · filed 2021-05-04
2019-12-31$12.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$378.00K
derived: sum of 2 quarters · filed 2021-02-25
-$304.00K
derived: sum of 3 quarters · filed 2021-02-25
$1.45M
10-K · filed 2021-02-25
2019-09-30$366.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
-$316.00K
derived: sum of 2 quarters · filed 2020-11-05
$1.44M
10-Q · filed 2020-11-05
$1.54M
derived: sum of 4 quarters · filed 2020-11-05
2019-06-30-$682.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
$1.07M
10-Q · filed 2020-08-06
$1.18M
derived: sum of 3 quarters · filed 2020-08-06
$1.20M
derived: sum of 4 quarters · filed 2020-08-06
2019-03-31$1.75M
10-Q · filed 2020-04-30
$1.86M
derived: sum of 2 quarters · filed 2020-04-30
$1.88M
derived: sum of 3 quarters · filed 2020-04-30
$917.00K
derived: sum of 4 quarters · filed 2020-04-30
2018-12-31$103.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$126.00K
derived: sum of 2 quarters · filed 2020-02-27
-$838.00K
derived: sum of 3 quarters · filed 2020-02-27
-$169.00K
10-K · filed 2020-02-27
2018-09-30$23.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
-$941.00K
derived: sum of 2 quarters · filed 2019-11-07
-$272.00K
10-Q · filed 2019-11-07
$3.91M
derived: sum of 4 quarters · filed 2019-11-07
2018-06-30-$964.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01
-$295.00K
10-Q · filed 2019-08-01
$3.88M
derived: sum of 3 quarters · filed 2019-08-01
2018-03-31$669.00K
10-Q · filed 2019-05-02
$4.85M
derived: sum of 2 quarters · filed 2019-05-02
2017-12-31$4.18M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$5.49M
10-K · filed 2019-02-28
2017-09-30$1.31M
10-Q · filed 2018-11-01
2016-12-31$601.00K
10-K · filed 2019-02-28
2014-06-30-$2.25M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12
$81.39M
10-Q · filed 2014-08-12
2014-03-31$83.64M
10-Q · filed 2014-05-14
2013-06-30-$1.28M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12
-$1.37M
10-Q · filed 2014-08-12
2013-03-31-$83.00K
10-Q · filed 2014-05-14